Sevil Sadri

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Ahmet Emre Eşkazan, Sevil Sadri, Dilek Keskin et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 25 citations

Hematological Malignancy, Early Molecular Response, Oncology +10

Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income Country

Serdar Şahin, Sevil Sadri, Zafer Başlar et al. · Clinical and Applied Thrombosis/Hemostasis · 2019 · 20 citations · Full text

Middle-income Country, Orthopaedic Surgery, Osteoporosis +16

The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly

Fatma Ela Keskin, Demet Özgil Yetkin, Hande Mefkure Özkaya et al. · Journal of Endocrinological Investigation · 2015 · 17 citations

Unrecognized Acromegaly, Surgeries Patients

A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran et al. · Turkish Journal of Hematology · 2019 · 14 citations · Full text

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden et al. · Turkish Journal of Hematology · 2021 · 11 citations · Full text